Department of Otolaryngology, Head and Neck Surgery, Division of Facial Plastic and Reconstructive Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Otolaryngology-Head and Neck Surgery, Division of Facial Plastic and Reconstructive Surgery, University of Washington School of Medicine, Seattle, WA, USA.
Aesthet Surg J. 2021 Jul 14;41(8):NP1053-NP1060. doi: 10.1093/asj/sjab116.
Nonsurgical rejuvenation of the tear trough area via the use of injectable filler material has become a popular procedure in facial rejuvenation. This procedure offers immediate, albeit temporary, results with minimal recovery time.
The aim of this systematic review was to report on patient satisfaction and complication rates to further guide practitioners.
PubMed, Cochrane, and Scopus libraries were queried for articles containing relevant terms. Articles with more than 5 patients who reported on satisfaction and/or complications from the procedure were included for review. In addition to these variables, we noted other aspects of injection, including filler material, technique, and needle or cannula delivery. Studies that did not otherwise fulfill inclusion criteria for statistical analysis but reported on intravascular injection-related complications were cited.
Initial query resulted in 1655 studies which were assessed for duplicates and inclusion/exclusion criteria. After screening, 28 articles were included for analysis. In total, 1956 patients were captured who had been injected with 1 of 4 materials: hyaluronic acid (1535), calcium hydroxyapatite (376), autologous fibroblast/keratin gel (35), and collagen-based filler (10). Short- and long-term satisfaction rates were 84.4% and 76.7%, respectively. Minor complications were common (44%). Secondarily, we found the use of cannula for filler injection of this region to be associated with a lower rate of ecchymosis (7% vs 17%, P < 0.05).
Filler injection volumization of tear trough deformity is an effective technique for facial rejuvenation associated with high patient satisfaction. Multiple filler materials offer acceptable satisfaction and complication profiles.
通过注射填充材料对泪槽区域进行非手术年轻化已成为面部年轻化的一种流行方法。该方法具有即时效果(尽管是暂时的),且恢复期极短。
本系统评价旨在报告患者满意度和并发症发生率,以进一步为从业者提供指导。
在 PubMed、Cochrane 和 Scopus 库中查询包含相关术语的文章。纳入报道了该程序满意度和/或并发症的患者超过 5 例的文章进行综述。除了这些变量,我们还注意到注射的其他方面,包括填充材料、技术以及针或套管的输送。引用了未满足其他纳入标准但报告了与血管内注射相关并发症的研究。
最初的查询得到了 1655 项研究,对这些研究进行了重复评估和纳入/排除标准评估。筛选后,有 28 篇文章被纳入分析。共有 1956 例患者接受了 4 种材料之一的注射:透明质酸(1535 例)、羟基磷灰石钙(376 例)、自体成纤维细胞/角蛋白凝胶(35 例)和基于胶原的填充物(10 例)。短期和长期满意度分别为 84.4%和 76.7%。常见轻微并发症(44%)。其次,我们发现该区域填充剂注射使用套管与瘀斑发生率较低(7%比 17%,P<0.05)相关。
泪槽畸形的填充物注射体积成形术是一种有效的面部年轻化技术,患者满意度高。多种填充材料具有可接受的满意度和并发症特征。